A risk management programme is a condition of supply of this product.
This site contains registration forms for prescribers, pharmacists and patients. Additionally, materials
for healthcare professionals are available for many countries and can be accessed from this site.
Any unlawful attempt to obtain thalidomide will be reported to the
Medicines and Healthcare products Regulatory Authority (UK)
and the relevant regulatory enforcement agency in each country.
To request login information, please email info-prmp@pharmion.com | |
 |
Please Log in:
 |
|
|
|
|